
BioMark Announces the Final Closing of Oversubscribed Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark
The latest information about BioMark Diagnostics to keep you up to date.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark

Personal Reflection: A Shared Journey of Loss and Hope My journey with BioMark Diagnostics is

BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 BioMark is

From Black Plastics to Biomarkers How Environmental Causes of Cancer Can Be Prevented Seemingly harmless

Cancer is Rising Among Young Women: Early Detection of Lung Cancer Lung cancer rates are

Cancer Prevention: 5 Actionable Steps Take control of your health and reduce your cancer risk

BioMark’s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered

BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection BioMark
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]